JP2020522535A5 - - Google Patents

Download PDF

Info

Publication number
JP2020522535A5
JP2020522535A5 JP2019567345A JP2019567345A JP2020522535A5 JP 2020522535 A5 JP2020522535 A5 JP 2020522535A5 JP 2019567345 A JP2019567345 A JP 2019567345A JP 2019567345 A JP2019567345 A JP 2019567345A JP 2020522535 A5 JP2020522535 A5 JP 2020522535A5
Authority
JP
Japan
Prior art keywords
amino acid
acid sequence
antibody
seq
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019567345A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020522535A (ja
JP7247113B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/036261 external-priority patent/WO2018226833A1/en
Publication of JP2020522535A publication Critical patent/JP2020522535A/ja
Publication of JP2020522535A5 publication Critical patent/JP2020522535A5/ja
Priority to JP2023041296A priority Critical patent/JP7777096B2/ja
Application granted granted Critical
Publication of JP7247113B2 publication Critical patent/JP7247113B2/ja
Priority to JP2024231213A priority patent/JP2025066722A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019567345A 2017-06-06 2018-06-06 ミクログリアの活性化を抑制する方法 Active JP7247113B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2023041296A JP7777096B2 (ja) 2017-06-06 2023-03-15 ミクログリアの活性化を抑制する方法
JP2024231213A JP2025066722A (ja) 2017-06-06 2024-12-26 ミクログリアの活性化を抑制する方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762515711P 2017-06-06 2017-06-06
US62/515,711 2017-06-06
PCT/US2018/036261 WO2018226833A1 (en) 2017-06-06 2018-06-06 Methods of suppressing microglial activation

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023041296A Division JP7777096B2 (ja) 2017-06-06 2023-03-15 ミクログリアの活性化を抑制する方法

Publications (3)

Publication Number Publication Date
JP2020522535A JP2020522535A (ja) 2020-07-30
JP2020522535A5 true JP2020522535A5 (https=) 2021-05-27
JP7247113B2 JP7247113B2 (ja) 2023-03-28

Family

ID=64566373

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2019567345A Active JP7247113B2 (ja) 2017-06-06 2018-06-06 ミクログリアの活性化を抑制する方法
JP2023041296A Active JP7777096B2 (ja) 2017-06-06 2023-03-15 ミクログリアの活性化を抑制する方法
JP2024231213A Pending JP2025066722A (ja) 2017-06-06 2024-12-26 ミクログリアの活性化を抑制する方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2023041296A Active JP7777096B2 (ja) 2017-06-06 2023-03-15 ミクログリアの活性化を抑制する方法
JP2024231213A Pending JP2025066722A (ja) 2017-06-06 2024-12-26 ミクログリアの活性化を抑制する方法

Country Status (5)

Country Link
US (2) US20200165338A1 (https=)
EP (1) EP3634478A4 (https=)
JP (3) JP7247113B2 (https=)
CA (1) CA3066353A1 (https=)
WO (1) WO2018226833A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4125939A4 (en) * 2020-03-25 2024-04-24 The Brigham & Women's Hospital, Inc. INHALATE XENON THERAPY FOR NEURODEGENERATIVE DISEASES
WO2021231566A1 (en) * 2020-05-12 2021-11-18 Massachusetts Institute Of Technology The use of choline supplementation as therapy for apoe4-related disorders
IL297697A (en) * 2020-06-17 2022-12-01 Tiziana Life Sciences Plc Preparations and methods for improving chimeric antigen receptor t cell therapies
CN116406274B (zh) * 2020-07-30 2026-02-17 迪赞纳生命科学公开有限公司 用于治疗冠状病毒的cd3抗体
WO2023064942A1 (en) * 2021-10-14 2023-04-20 Tiziana Life Sciences Plc Methods of suppressing microglial activation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7205280B2 (en) * 1998-03-11 2007-04-17 Cognosci, Inc. Methods of suppressing microglial activation
CA2569509C (en) * 2004-06-03 2014-08-12 Novimmune S.A. Anti-cd3 antibodies and methods of use thereof
CN101309703A (zh) * 2005-09-12 2008-11-19 诺维莫尼公司 抗cd3抗体组合物
CN116617387A (zh) * 2016-08-29 2023-08-22 迪赞纳生命科学公开有限公司 抗cd3抗体制剂

Similar Documents

Publication Publication Date Title
JP2020522535A5 (https=)
RU2006123481A (ru) Nogo-a-нейтрализующие иммуноглобулины для лечения неврологических заболеваний
JP2019522961A5 (https=)
JP2020500538A5 (https=)
JP2013507991A5 (https=)
JP2012504634A5 (https=)
JP2012504955A5 (https=)
JP2014524748A5 (https=)
JP2009511480A5 (https=)
JP2011506483A5 (https=)
JP2017528476A5 (https=)
JP2016529229A5 (https=)
JP2011528902A5 (https=)
JP2018527000A5 (https=)
RU2010123888A (ru) Axl-антитела
JP2006522830A5 (https=)
JP2010526087A (ja) 抗il−5抗体を投与するための方法
CA2494008A1 (en) Anti-myelin associated glycoprotein (mag) antibodies
JP2019527194A5 (https=)
JP2017534646A5 (https=)
JP2019534003A5 (https=)
JP2017507131A5 (https=)
JP7247113B2 (ja) ミクログリアの活性化を抑制する方法
JP2018529661A5 (https=)
JP2013521252A5 (https=)